Gene Symbol | Gene ID | Gene Info |
---|---|---|
HMGA1
|
ENSG00000137309.15 | high mobility group AT-hook 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_34207754_34207905 | HMGA1 | 1261 | 0.485388 | -0.65 | 5.6e-02 | Click! |
chr6_34163902_34164148 | HMGA1 | 40625 | 0.138022 | -0.63 | 6.8e-02 | Click! |
chr6_34208227_34208378 | HMGA1 | 1734 | 0.381731 | -0.42 | 2.7e-01 | Click! |
chr6_34207394_34207687 | HMGA1 | 972 | 0.584661 | -0.37 | 3.2e-01 | Click! |
chr6_34191397_34191748 | HMGA1 | 13078 | 0.200090 | -0.32 | 4.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_40532306_40532606 | 2.45 |
ENSG00000212553 |
. |
101092 |
0.08 |
chr4_78737672_78737823 | 2.09 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
2470 |
0.38 |
chr2_235361916_235362359 | 1.92 |
ARL4C |
ADP-ribosylation factor-like 4C |
43107 |
0.21 |
chr8_66751756_66751954 | 1.77 |
PDE7A |
phosphodiesterase 7A |
872 |
0.73 |
chr12_64480628_64481033 | 1.73 |
RP11-196H14.2 |
|
10568 |
0.2 |
chr6_106969857_106970345 | 1.69 |
AIM1 |
absent in melanoma 1 |
10371 |
0.2 |
chrX_78400540_78401325 | 1.67 |
GPR174 |
G protein-coupled receptor 174 |
25537 |
0.27 |
chr4_154390309_154390666 | 1.66 |
KIAA0922 |
KIAA0922 |
2986 |
0.33 |
chr19_42056193_42056486 | 1.66 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
453 |
0.8 |
chrX_78343760_78343985 | 1.64 |
GPR174 |
G protein-coupled receptor 174 |
82597 |
0.11 |
chr1_108477311_108477544 | 1.60 |
VAV3-AS1 |
VAV3 antisense RNA 1 |
29638 |
0.19 |
chr10_6626003_6626633 | 1.59 |
PRKCQ |
protein kinase C, theta |
4055 |
0.36 |
chr19_42056498_42056882 | 1.58 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
804 |
0.6 |
chr16_79630640_79632238 | 1.58 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
2360 |
0.43 |
chr2_109238478_109238884 | 1.57 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
959 |
0.64 |
chr4_48134207_48134444 | 1.57 |
TXK |
TXK tyrosine kinase |
1948 |
0.29 |
chr14_99725147_99725681 | 1.52 |
AL109767.1 |
|
3871 |
0.26 |
chr2_120687963_120688114 | 1.52 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
686 |
0.74 |
chr3_111261315_111261845 | 1.51 |
CD96 |
CD96 molecule |
583 |
0.82 |
chr12_27093749_27094602 | 1.51 |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
2742 |
0.2 |
chr2_204574340_204574491 | 1.46 |
CD28 |
CD28 molecule |
2999 |
0.33 |
chr6_151701170_151702048 | 1.44 |
ENSG00000252615 |
. |
2375 |
0.22 |
chr20_39676850_39677439 | 1.42 |
TOP1 |
topoisomerase (DNA) I |
19686 |
0.2 |
chr4_148982006_148982383 | 1.42 |
RP11-76G10.1 |
|
85428 |
0.1 |
chr4_40202041_40202542 | 1.41 |
RHOH |
ras homolog family member H |
327 |
0.9 |
chr12_47607778_47608233 | 1.41 |
PCED1B |
PC-esterase domain containing 1B |
2047 |
0.36 |
chr8_100714756_100715301 | 1.41 |
ENSG00000243254 |
. |
88722 |
0.08 |
chr2_186509945_186510096 | 1.39 |
ENSG00000212581 |
. |
16481 |
0.26 |
chr18_21572812_21573447 | 1.39 |
TTC39C |
tetratricopeptide repeat domain 39C |
392 |
0.85 |
chr7_46104168_46104319 | 1.38 |
ENSG00000239004 |
. |
89206 |
0.09 |
chr18_48718913_48719435 | 1.36 |
MEX3C |
mex-3 RNA binding family member C |
3955 |
0.31 |
chr1_101587818_101587969 | 1.34 |
ENSG00000252765 |
. |
10816 |
0.2 |
chr12_867200_867553 | 1.32 |
WNK1 |
WNK lysine deficient protein kinase 1 |
4644 |
0.24 |
chr10_90759119_90759378 | 1.29 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
8101 |
0.15 |
chr5_35858265_35858416 | 1.28 |
IL7R |
interleukin 7 receptor |
1346 |
0.46 |
chr1_209942353_209942874 | 1.27 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
653 |
0.63 |
chr13_99953472_99953749 | 1.27 |
GPR183 |
G protein-coupled receptor 183 |
6049 |
0.22 |
chr3_108541842_108541993 | 1.25 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
298 |
0.94 |
chr2_204572133_204572358 | 1.24 |
CD28 |
CD28 molecule |
829 |
0.71 |
chr10_8099206_8099457 | 1.23 |
GATA3 |
GATA binding protein 3 |
2562 |
0.44 |
chr17_37932472_37932886 | 1.22 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
1799 |
0.27 |
chr5_130882612_130883040 | 1.22 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
14100 |
0.29 |
chrX_73071645_73072457 | 1.22 |
RP13-216E22.5 |
|
117269 |
0.06 |
chrY_18689566_18689717 | 1.21 |
ENSG00000252323 |
. |
241372 |
0.02 |
chr12_57077777_57078354 | 1.21 |
PTGES3 |
prostaglandin E synthase 3 (cytosolic) |
3881 |
0.14 |
chr4_84035334_84035716 | 1.20 |
PLAC8 |
placenta-specific 8 |
343 |
0.91 |
chr14_99732558_99733007 | 1.20 |
AL109767.1 |
|
3497 |
0.26 |
chr4_109086470_109087224 | 1.20 |
LEF1 |
lymphoid enhancer-binding factor 1 |
610 |
0.72 |
chr1_192546230_192546423 | 1.19 |
RGS1 |
regulator of G-protein signaling 1 |
1423 |
0.45 |
chr2_109239146_109239415 | 1.19 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
1558 |
0.46 |
chr1_167485802_167485953 | 1.19 |
CD247 |
CD247 molecule |
1898 |
0.36 |
chr14_102289544_102289975 | 1.19 |
CTD-2017C7.2 |
|
13101 |
0.14 |
chr6_25041553_25042305 | 1.18 |
RP3-425P12.5 |
|
138 |
0.72 |
chr2_204801338_204802214 | 1.17 |
ICOS |
inducible T-cell co-stimulator |
273 |
0.95 |
chr13_99910339_99910626 | 1.17 |
GPR18 |
G protein-coupled receptor 18 |
146 |
0.96 |
chr5_180076761_180077042 | 1.17 |
FLT4 |
fms-related tyrosine kinase 4 |
277 |
0.92 |
chr12_125413370_125413521 | 1.16 |
UBC |
ubiquitin C |
11531 |
0.16 |
chr2_204572665_204572956 | 1.16 |
CD28 |
CD28 molecule |
1394 |
0.52 |
chr1_190211002_190211153 | 1.16 |
RP11-547I7.1 |
|
22951 |
0.29 |
chr12_15111636_15111984 | 1.15 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
2390 |
0.25 |
chr21_25801249_25801648 | 1.15 |
ENSG00000232512 |
. |
671997 |
0.0 |
chr4_143325352_143326244 | 1.15 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
26614 |
0.28 |
chr12_92270534_92270711 | 1.15 |
C12orf79 |
chromosome 12 open reading frame 79 |
260175 |
0.02 |
chr3_151965779_151965930 | 1.15 |
MBNL1 |
muscleblind-like splicing regulator 1 |
19975 |
0.21 |
chr3_156201429_156202178 | 1.14 |
KCNAB1-AS1 |
KCNAB1 antisense RNA 1 |
37109 |
0.17 |
chr3_108542080_108542294 | 1.14 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
568 |
0.83 |
chr12_14571201_14571607 | 1.14 |
ATF7IP |
activating transcription factor 7 interacting protein |
666 |
0.77 |
chr12_25206187_25206540 | 1.14 |
LRMP |
lymphoid-restricted membrane protein |
689 |
0.71 |
chr14_58820285_58820720 | 1.13 |
ARID4A |
AT rich interactive domain 4A (RBP1-like) |
22497 |
0.11 |
chr8_99614241_99614392 | 1.12 |
KB-1205A7.2 |
|
1165 |
0.62 |
chr8_29955696_29955905 | 1.12 |
LEPROTL1 |
leptin receptor overlapping transcript-like 1 |
2635 |
0.22 |
chr5_156609052_156609245 | 1.12 |
ITK |
IL2-inducible T-cell kinase |
1311 |
0.34 |
chr6_148556457_148556608 | 1.12 |
SASH1 |
SAM and SH3 domain containing 1 |
36908 |
0.17 |
chr6_144666173_144666513 | 1.10 |
UTRN |
utrophin |
1106 |
0.59 |
chr4_30940531_30940682 | 1.10 |
RP11-619J20.1 |
|
145014 |
0.05 |
chr17_74749298_74749501 | 1.10 |
ENSG00000200257 |
. |
405 |
0.71 |
chr13_99222825_99223522 | 1.09 |
STK24 |
serine/threonine kinase 24 |
5944 |
0.22 |
chr1_160548517_160548751 | 1.09 |
CD84 |
CD84 molecule |
629 |
0.67 |
chr1_198608588_198608957 | 1.09 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
480 |
0.86 |
chr2_191224464_191225199 | 1.07 |
INPP1 |
inositol polyphosphate-1-phosphatase |
3569 |
0.24 |
chr5_110561342_110561544 | 1.07 |
CAMK4 |
calcium/calmodulin-dependent protein kinase IV |
1659 |
0.44 |
chr10_32664058_32664317 | 1.07 |
EPC1 |
enhancer of polycomb homolog 1 (Drosophila) |
3539 |
0.18 |
chr7_104908860_104909472 | 1.07 |
SRPK2 |
SRSF protein kinase 2 |
296 |
0.92 |
chr2_12596554_12597065 | 1.07 |
ENSG00000207183 |
. |
45182 |
0.2 |
chr11_128384304_128384833 | 1.07 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
7528 |
0.24 |
chr20_14314803_14314963 | 1.07 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
3371 |
0.3 |
chr9_105944429_105944580 | 1.06 |
CYLC2 |
cylicin, basic protein of sperm head cytoskeleton 2 |
186878 |
0.03 |
chr3_98264792_98264943 | 1.06 |
GPR15 |
G protein-coupled receptor 15 |
14124 |
0.14 |
chr2_143887894_143888150 | 1.06 |
ARHGAP15 |
Rho GTPase activating protein 15 |
1139 |
0.61 |
chr10_105728102_105728505 | 1.06 |
SLK |
STE20-like kinase |
1344 |
0.4 |
chr13_49228156_49228383 | 1.05 |
CYSLTR2 |
cysteinyl leukotriene receptor 2 |
52682 |
0.15 |
chr2_148694124_148694275 | 1.05 |
ENSG00000265049 |
. |
4441 |
0.23 |
chr1_93003304_93003455 | 1.05 |
GFI1 |
growth factor independent 1 transcription repressor |
50946 |
0.15 |
chr1_67398755_67399224 | 1.04 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
3063 |
0.27 |
chrX_78401406_78401924 | 1.04 |
GPR174 |
G protein-coupled receptor 174 |
24804 |
0.27 |
chr6_11986707_11986858 | 1.04 |
RP11-456H18.1 |
|
5463 |
0.27 |
chr5_56473598_56474064 | 1.04 |
GPBP1 |
GC-rich promoter binding protein 1 |
2058 |
0.37 |
chr20_25423757_25423908 | 1.04 |
GINS1 |
GINS complex subunit 1 (Psf1 homolog) |
35467 |
0.15 |
chr12_92524835_92525431 | 1.03 |
C12orf79 |
chromosome 12 open reading frame 79 |
5664 |
0.19 |
chr14_23038615_23038766 | 1.03 |
AE000662.93 |
|
12734 |
0.1 |
chr12_10020930_10021432 | 1.03 |
CLEC2B |
C-type lectin domain family 2, member B |
1554 |
0.25 |
chr13_42970913_42971064 | 1.02 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
124699 |
0.06 |
chr12_82794563_82794714 | 1.02 |
METTL25 |
methyltransferase like 25 |
1500 |
0.48 |
chr22_31691697_31692040 | 1.02 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
3348 |
0.14 |
chr6_159237653_159237805 | 1.02 |
EZR-AS1 |
EZR antisense RNA 1 |
1314 |
0.35 |
chr12_865415_865972 | 1.02 |
WNK1 |
WNK lysine deficient protein kinase 1 |
2961 |
0.28 |
chr3_151921407_151921835 | 1.01 |
MBNL1 |
muscleblind-like splicing regulator 1 |
64208 |
0.12 |
chr11_128377186_128378036 | 1.01 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2322 |
0.36 |
chr14_61793878_61794206 | 1.01 |
PRKCH |
protein kinase C, eta |
411 |
0.85 |
chr8_101318929_101319279 | 1.01 |
RNF19A |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
2650 |
0.33 |
chr1_205599470_205599752 | 1.00 |
ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1) |
1479 |
0.36 |
chr2_138171827_138171978 | 1.00 |
ENSG00000212425 |
. |
97878 |
0.09 |
chr1_158901311_158901684 | 1.00 |
PYHIN1 |
pyrin and HIN domain family, member 1 |
139 |
0.97 |
chr12_14539259_14539925 | 1.00 |
ATF7IP |
activating transcription factor 7 interacting protein |
1594 |
0.47 |
chr11_117861027_117861203 | 1.00 |
IL10RA |
interleukin 10 receptor, alpha |
4006 |
0.22 |
chr12_12873301_12873452 | 1.00 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
2581 |
0.19 |
chr18_12775334_12775517 | 1.00 |
ENSG00000201466 |
. |
14709 |
0.18 |
chr12_40077019_40077550 | 1.00 |
C12orf40 |
chromosome 12 open reading frame 40 |
57299 |
0.13 |
chr7_7960484_7960678 | 0.99 |
ENSG00000201747 |
. |
14431 |
0.18 |
chr17_37932973_37933124 | 0.99 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
1430 |
0.33 |
chr5_148189087_148189390 | 0.99 |
ADRB2 |
adrenoceptor beta 2, surface |
16918 |
0.25 |
chr4_98424505_98424656 | 0.99 |
ENSG00000271995 |
. |
16623 |
0.29 |
chr11_3010488_3011464 | 0.98 |
AC131971.1 |
HCG1782999; PRO0943; Uncharacterized protein |
117 |
0.83 |
chr6_62734278_62734429 | 0.98 |
KHDRBS2 |
KH domain containing, RNA binding, signal transduction associated 2 |
261779 |
0.02 |
chr3_108545094_108545352 | 0.98 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
3604 |
0.32 |
chr5_39058064_39058293 | 0.98 |
RICTOR |
RPTOR independent companion of MTOR, complex 2 |
16313 |
0.24 |
chr18_9120826_9120977 | 0.98 |
RP11-143J12.3 |
|
5026 |
0.17 |
chr10_63997623_63997774 | 0.98 |
RTKN2 |
rhotekin 2 |
1676 |
0.5 |
chr2_204804846_204805205 | 0.97 |
ICOS |
inducible T-cell co-stimulator |
3522 |
0.34 |
chr1_158902219_158902370 | 0.97 |
PYHIN1 |
pyrin and HIN domain family, member 1 |
936 |
0.62 |
chr6_130717839_130718014 | 0.97 |
TMEM200A |
transmembrane protein 200A |
24321 |
0.19 |
chr9_111863720_111864238 | 0.97 |
TMEM245 |
transmembrane protein 245 |
14406 |
0.18 |
chr7_147299362_147299513 | 0.97 |
CNTNAP2 |
contactin associated protein-like 2 |
36464 |
0.21 |
chr11_110166052_110166239 | 0.97 |
RDX |
radixin |
1192 |
0.65 |
chr12_118796178_118796667 | 0.96 |
TAOK3 |
TAO kinase 3 |
488 |
0.85 |
chr18_9140205_9140762 | 0.96 |
ANKRD12 |
ankyrin repeat domain 12 |
2922 |
0.21 |
chr17_29640754_29641122 | 0.96 |
EVI2B |
ecotropic viral integration site 2B |
164 |
0.93 |
chr3_151962421_151962590 | 0.96 |
MBNL1 |
muscleblind-like splicing regulator 1 |
23324 |
0.2 |
chr10_22956019_22956170 | 0.96 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
46943 |
0.18 |
chr8_27237778_27238009 | 0.96 |
PTK2B |
protein tyrosine kinase 2 beta |
275 |
0.93 |
chrX_30594869_30596024 | 0.95 |
CXorf21 |
chromosome X open reading frame 21 |
515 |
0.84 |
chr17_14104811_14105106 | 0.95 |
AC005224.2 |
|
8847 |
0.21 |
chr6_24935630_24936094 | 0.95 |
FAM65B |
family with sequence similarity 65, member B |
326 |
0.92 |
chr17_37931532_37931849 | 0.95 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
2788 |
0.2 |
chr9_95716277_95716712 | 0.95 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
6761 |
0.23 |
chr2_237446552_237446703 | 0.94 |
ACKR3 |
atypical chemokine receptor 3 |
29803 |
0.19 |
chr14_41553789_41553940 | 0.94 |
ENSG00000221695 |
. |
264633 |
0.02 |
chr13_48984001_48984152 | 0.94 |
LPAR6 |
lysophosphatidic acid receptor 6 |
16967 |
0.26 |
chr1_198620819_198621442 | 0.94 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
12838 |
0.23 |
chr8_18588843_18589142 | 0.94 |
RP11-161I2.1 |
|
10577 |
0.25 |
chr1_66799510_66799957 | 0.94 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
1861 |
0.5 |
chr1_198492691_198493057 | 0.94 |
ATP6V1G3 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
16930 |
0.28 |
chr12_67107724_67108271 | 0.93 |
GRIP1 |
glutamate receptor interacting protein 1 |
35072 |
0.24 |
chr14_99655246_99655958 | 0.93 |
AL162151.4 |
|
30849 |
0.2 |
chr7_35866337_35866488 | 0.93 |
SEPT7 |
septin 7 |
5288 |
0.24 |
chr14_53593743_53594005 | 0.92 |
DDHD1 |
DDHD domain containing 1 |
22930 |
0.17 |
chrX_49120810_49120961 | 0.92 |
FOXP3 |
forkhead box P3 |
403 |
0.7 |
chr13_41554921_41555161 | 0.92 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
1377 |
0.45 |
chr5_67576418_67576636 | 0.91 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
392 |
0.92 |
chr21_35305474_35305968 | 0.91 |
LINC00649 |
long intergenic non-protein coding RNA 649 |
2203 |
0.25 |
chr12_10018822_10019014 | 0.91 |
RP11-290C10.1 |
|
708 |
0.58 |
chr1_236680510_236680661 | 0.91 |
LGALS8 |
lectin, galactoside-binding, soluble, 8 |
715 |
0.64 |
chr1_212360214_212360441 | 0.91 |
ENSG00000252879 |
. |
87309 |
0.07 |
chr10_14613286_14613530 | 0.91 |
FAM107B |
family with sequence similarity 107, member B |
621 |
0.79 |
chr13_34115724_34116261 | 0.91 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
191225 |
0.03 |
chrX_26290771_26290922 | 0.91 |
MAGEB5 |
melanoma antigen family B, 5 |
55427 |
0.16 |
chrX_83838309_83838460 | 0.91 |
HDX |
highly divergent homeobox |
80897 |
0.11 |
chr4_40230194_40230420 | 0.90 |
RHOH |
ras homolog family member H |
28343 |
0.18 |
chr12_10021470_10021931 | 0.90 |
CLEC2B |
C-type lectin domain family 2, member B |
1035 |
0.4 |
chr3_69140694_69141185 | 0.90 |
ARL6IP5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
6767 |
0.15 |
chr16_55560266_55560417 | 0.90 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
2064 |
0.36 |
chr12_69635649_69635920 | 0.90 |
CPSF6 |
cleavage and polyadenylation specific factor 6, 68kDa |
2362 |
0.37 |
chr4_94277865_94278016 | 0.90 |
RP11-703C10.1 |
|
37003 |
0.23 |
chr7_148637323_148637474 | 0.89 |
ENSG00000252310 |
. |
1182 |
0.4 |
chrX_78202733_78203002 | 0.89 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
1949 |
0.5 |
chr15_60881361_60881613 | 0.89 |
RORA |
RAR-related orphan receptor A |
3253 |
0.29 |
chr7_45279562_45279713 | 0.89 |
RAMP3 |
receptor (G protein-coupled) activity modifying protein 3 |
82209 |
0.08 |
chr6_154365939_154366090 | 0.89 |
OPRM1 |
opioid receptor, mu 1 |
5384 |
0.35 |
chr8_29953492_29954050 | 0.89 |
LEPROTL1 |
leptin receptor overlapping transcript-like 1 |
606 |
0.68 |
chr14_92331424_92331867 | 0.89 |
TC2N |
tandem C2 domains, nuclear |
2228 |
0.32 |
chr3_141107290_141107620 | 0.89 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
801 |
0.69 |
chr3_63964903_63965338 | 0.89 |
ATXN7 |
ataxin 7 |
11700 |
0.14 |
chr11_3396508_3396659 | 0.89 |
ENSG00000263365 |
. |
1732 |
0.26 |
chr2_182325148_182325432 | 0.89 |
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
3135 |
0.38 |
chr13_48986760_48987238 | 0.89 |
LPAR6 |
lysophosphatidic acid receptor 6 |
14044 |
0.27 |
chr8_113763690_113763841 | 0.88 |
CSMD3 |
CUB and Sushi multiple domains 3 |
61494 |
0.15 |
chr16_80690406_80690960 | 0.88 |
ENSG00000265341 |
. |
8777 |
0.18 |
chr1_89735192_89735432 | 0.88 |
GBP5 |
guanylate binding protein 5 |
1234 |
0.47 |
chr2_109239563_109239806 | 0.88 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
1962 |
0.4 |
chr4_48135139_48135397 | 0.88 |
TXK |
TXK tyrosine kinase |
1005 |
0.5 |
chrY_7852399_7852550 | 0.88 |
RFTN1P1 |
raftlin, lipid raft linker 1 pseudogene 1 |
207726 |
0.03 |
chr4_163516062_163516213 | 0.88 |
FSTL5 |
follistatin-like 5 |
430950 |
0.01 |
chr15_58921290_58921613 | 0.88 |
ENSG00000239100 |
. |
29017 |
0.15 |
chr7_50351765_50352753 | 0.87 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
3941 |
0.34 |
chr12_40012002_40012194 | 0.87 |
ABCD2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
1455 |
0.48 |
chr14_99726303_99726510 | 0.87 |
AL109767.1 |
|
2879 |
0.29 |
chr12_92949870_92950021 | 0.87 |
ENSG00000238865 |
. |
11182 |
0.27 |
chr6_152504718_152504928 | 0.87 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
15324 |
0.29 |
chr11_109633690_109633841 | 0.87 |
RP11-708B6.2 |
|
179132 |
0.03 |
chr6_144665292_144666004 | 0.87 |
UTRN |
utrophin |
411 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 7.9 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.3 | 1.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.2 | 3.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 3.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
1.0 | 3.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.0 | 3.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.9 | 4.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.8 | 2.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 1.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.6 | 1.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 1.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 5.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 0.5 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.5 | 1.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 2.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 1.8 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 1.7 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 1.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.3 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.4 | 3.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 3.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.8 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.4 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 2.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.3 | 0.7 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 3.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 0.6 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.3 | 0.8 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.8 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 1.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 5.9 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 1.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.2 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.5 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.2 | 0.4 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 0.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.7 | GO:0031063 | regulation of histone deacetylation(GO:0031063) positive regulation of histone deacetylation(GO:0031065) |
0.2 | 0.4 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 10.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.6 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.4 | GO:1903514 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.2 | 0.8 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.4 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 0.7 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.6 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 1.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.5 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.7 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.4 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.4 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 3.4 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 3.2 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.1 | 0.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 1.8 | GO:1900181 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.1 | 1.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.3 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 1.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.8 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 1.2 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 1.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 2.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 3.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 1.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 2.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.6 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.2 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.7 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.2 | GO:0032633 | interleukin-4 production(GO:0032633) regulation of interleukin-4 production(GO:0032673) negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:1903726 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 1.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 1.7 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 0.1 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.1 | 2.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.9 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 1.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 1.0 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 1.6 | GO:0030835 | regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 4.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.4 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.1 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.4 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) modulation of growth of symbiont involved in interaction with host(GO:0044144) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.2 | GO:0021612 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 1.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.1 | 0.5 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:1904375 | regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 0.1 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0022009 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.4 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.7 | GO:0035637 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:0021894 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 1.7 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.2 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.1 | 0.2 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.3 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.5 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 4.0 | GO:0051320 | S phase(GO:0051320) |
0.0 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.2 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.4 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.3 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.7 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.7 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0009189 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.0 | 0.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.2 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 1.1 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) regulation of mesoderm development(GO:2000380) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.7 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.0 | 4.6 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0098930 | anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 5.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.3 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.0 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 1.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.2 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.6 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ morphogenesis(GO:0048563) post-embryonic organ development(GO:0048569) |
0.0 | 0.3 | GO:1903902 | positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
0.0 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.3 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.1 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.5 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.4 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.0 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.0 | 0.0 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.0 | 0.6 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 2.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.2 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.0 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.3 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.1 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.2 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 1.3 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0042168 | porphyrin-containing compound metabolic process(GO:0006778) heme metabolic process(GO:0042168) |
0.0 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0098868 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.2 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.2 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0002708 | positive regulation of lymphocyte mediated immunity(GO:0002708) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.0 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.1 | GO:0035590 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 1.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.5 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.0 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.0 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.0 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 3.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 2.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 2.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 3.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 1.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.5 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.6 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.8 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 3.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.9 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.8 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.7 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 9.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 3.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 2.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 1.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 4.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.5 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 1.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 1.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 2.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.5 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.0 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.3 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 4.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 1.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 1.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 1.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.0 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 4.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 2.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.4 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 6.6 | GO:0005739 | mitochondrion(GO:0005739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 2.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 3.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 11.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 4.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 5.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 5.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.3 | 0.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 2.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 2.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 1.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 3.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 3.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 4.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 6.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 3.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.7 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 3.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 2.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 1.7 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 3.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 1.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.7 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.7 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.0 | GO:0015440 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 1.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 3.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 1.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 10.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 3.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.7 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.7 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 1.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 28.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 9.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 5.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 6.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 3.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 3.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 2.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 5.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 9.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 4.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 7.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 8.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 1.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 6.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 5.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 3.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 4.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 4.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 5.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 2.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 3.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 1.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |